Artal Group S.A. Bristol Myers Squibb CO Transaction History
Artal Group S.A.
- $214 Million
- Q3 2024
A detailed history of Artal Group S.A. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Artal Group S.A. holds 1,000,000 shares of BMY stock, worth $55.5 Million. This represents 1.69% of its overall portfolio holdings.
Number of Shares
1,000,000Holding current value
$55.5 Million% of portfolio
1.69%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BMY
# of Institutions
2,656Shares Held
1.47BCall Options Held
32.3MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA190MShares$10.5 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.81 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.16 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.33 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.35 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $118B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...